Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Creative Commons License

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.

OPEN MEDICINE, cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1515/med-2021-0216
  • Dergi Adı: OPEN MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.192-197
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background - Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.